EPISODE · Feb 6, 2026 · 2 MIN
Hims vs Novo Nordisk, Running vs at-home fitness, Women's performance research scores $50M
from Fitt Insider
February 6, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Hims launches compounded GLP-1 pill starting at $49/month as needle-free alternative, but Novo Nordisk threatens legal action over what it calls illegal compounding Women's Health, Sports, and Performance Medical Institute launches with $50M+ to fund injury prevention research for female athletes Peloton reports Q2 revenue of $656.5M missing expectations with paid subscribers down 7% year-over-year, while Brooks reports revenue up 16% marking ninth straight year of growth More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → [email protected]
Embed this episode
Ready to play
Hims vs Novo Nordisk, Running vs at-home fitness, Women's performance research scores $50M
No transcript for this episode yet
Similar Episodes
No similar episodes found.